News | Cardiovascular diseases

News

GPs back proposal to scrap community pharmacy blood pressure checks

The motion aimed to address community pharmacies’ unfair expectation to seek funding from schemes such as blood pressure checks “due to underfunding of their core national contract”.…

Published: 28 November 2024

News

Nearly 92% of atrial fibrillation patients in England anticoagulated, says NHS adviser

The UK Health Security Agency has achieved the figure five years ahead of its original 2029 target year by offering anticoagulation to nine in ten patients with atrial fibrillation.…

Published: 22 November 2024

News

BMA conference considers proposal to scrap community pharmacy blood pressure checks

The motion proposed by the Devon Local Medical Committee describes “wastefulness” of money spent on pharmacy blood pressure checks, which it says should instead fund pharmacy dispensing fees.…

Published: 20 November 2024

News

Statin prescribing in England at record high, show NICE data

Figures show that atorvastatin prescribing increased from 4.2 million people in 2022/2023 to 5.0 million people in 2023/2024.…

Published: 4 November 2024

News

Pharmacist-led cardiovascular disease interventions provide highest return on investment, says NHS report

The report measured return on investment over five years of a range of interventions, including smoking cessation, cardiovascular disease and substance abuse.…

Published: 10 October 2024

Feature

Warp drive: conducting experiments in space allows speedy results

Experiments in space with human tissue chips bring hope of discovering new ways of treating diseases back on Earth.…

Published: 3 October 2024

News

MHRA approves dupilumab for treatment of uncontrolled COPD

The regulator has granted marketing authorisation for a subcutaneous injection as an add-on maintenance treatment for adults with uncontrolled COPD.…

Published: 16 September 2024

News

Statins offer cost-effective benefit for older people, study results suggest

The researchers found that lifetime use of a standard statin therapy increased quality-adjusted life years by 0.24–0.70 per person.…

Published: 12 September 2024

News

More than 2,000 patients tested in UK’s first routine genotyping project for clopidogrel prescribing

Exclusive: The genotyping project at NHS Tayside identified 2,300 patients, 29% of whom emerged as ‘poor’ or ‘intermediate’ CYP2C19-clopidogrel metabolisers.…

Published: 19 August 2024

Opinion

Lessons from testing 2,300 patients at the UK’s first CYP2C19 genotyping system 

Specialist clinical pharmacist Alex Matos explains what his team has learned in the two years since setting up the NHS Tayside project to genotype acute stroke patients with an indication for clopidogrel.…

Published: 19 August 2024